Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth
- 14 February 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 62 (1) , 23-33
- https://doi.org/10.1016/0304-3835(92)90194-z
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Growth factors in development, transformation, and tumorigenesisCell, 1991
- A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorderAnti-Cancer Drugs, 1990
- The concentration of glucose in the culture medium determines the effect of suramin on the growth and differentiation of the human colonic adenocarcinoma cell clone HT29-D4Cancer Letters, 1990
- Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free mediumExperimental Cell Research, 1990
- Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell lineJournal of Cellular Physiology, 1990
- Behandlung des metastasierten Nebennierenkarzinoms mit SuraminDeutsche Medizinische Wochenschrift (1946), 1989
- Differentiation of a clone isolated from the HT29 cell line: polarized distribution of histocompatibility antigens (HLA) and of transferrin receptorsBiology of the Cell, 1988
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Suramin binds to platelet‐derived growth factor and inhibits its biological activityJournal of Cellular Biochemistry, 1985
- Suramin: With Special Reference to OnchocerciasisPublished by Elsevier ,1978